Weihan Zhao
Impact in
- Hepatology top 10%
- Hepatitis C virus research
Papers in
-
- Hepatitis C virus research 7
-
- HIV/AIDS drug development and treatment 4
- Co-authors
- Wei Liu (4 shared papers)Roger Trinh (2 shared papers)Armen Asatryan (4 shared papers)Jens Kort (4 shared papers)Matthew P. Kosloski (3 shared papers)Rajeev Menon (2 shared papers)Rolando M. Viani (1 shared paper)Thomas Prohaska (1 shared paper)
- Journals
- Antimicrobial Agents and Chemotherapy (3 papers)Arthritis & Rheumatology (2 papers)Journal of Hepatology (1 paper)Journal of Biopharmaceutical Statistics (1 paper)PLoS neglected tropical diseases (1 paper)
- Partner nations
- United StatesGermanySpain
In The Last Decade
Weihan Zhao
19 papers receiving 253 citations
Weihan Zhao's Hit Papers
Peers
Comparison fields: 5 of 67
- Hepatology 76
- Transplantation 9
- Epidemiology 83
- Emergency Medicine 20
- Infectious Diseases 42
Countries citing papers authored by Weihan Zhao
This map shows the geographic impact of Weihan Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weihan Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weihan Zhao more than expected).
Fields of papers citing papers by Weihan Zhao
This network shows the impact of papers produced by Weihan Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weihan Zhao. The network helps show where Weihan Zhao may publish in the future.
Co-authors
The 25 scholars most cited alongside Weihan Zhao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 63 | |
| 2 | 2016 | 29 | |
| 3 | A Phase 3 Trial of Upadacitinib for Giant-Cell Arteritis Hit paper breakdown → | 2025 | 25 |
| 4 | 2018 | 21 | |
| 5 | 2017 | 18 | |
| 6 | 2018 | 18 | |
| 7 | 2016 | 17 | |
| 8 | 2017 | 12 | |
| 9 | 2019 | 11 | |
| 10 | 2017 | 10 | |
| 11 | 2022 | 8 | |
| 12 | 2023 | 7 | |
| 13 | 2025 | 5 | |
| 14 | Identification of and intervention to address therapeutic gaps in care. | 2012 | 4 |
| 15 | 2025 | 3 | |
| 16 | 2023 | 3 | |
| 17 | 2015 | 3 | |
| 18 | 2015 | 3 | |
| 19 | 2018 | 1 | |
| 20 | 2025 | 0 |
About Weihan Zhao
Weihan Zhao is a scholar working on Hepatology, Infectious Diseases, Pulmonary and Respiratory Medicine, Surgery and Epidemiology, having authored 21 papers that have together received 261 indexed citations. Recurring topics across this work include Hepatitis C virus research (7 papers), HIV/AIDS drug development and treatment (4 papers), Vasculitis and related conditions (3 papers), Helicobacter pylori-related gastroenterology studies (2 papers), Pharmacogenetics and Drug Metabolism (1 paper), Click Chemistry and Applications (1 paper), TiO2 Photocatalysis and Solar Cells (1 paper) and Ammonia Synthesis and Nitrogen Reduction (1 paper). The work is most often cited by research in Hepatology (76 citations), Transplantation (9 citations), Epidemiology (83 citations), Emergency Medicine (20 citations) and Infectious Diseases (42 citations). Weihan Zhao has collaborated with scholars based in United States, Germany and Spain. Frequent co-authors include Wei Liu, Roger Trinh, Armen Asatryan, Jens Kort, Matthew P. Kosloski, Rajeev Menon, Rolando M. Viani, Thomas Prohaska, Arie Nouwen and Laurie Ruggiero. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Arthritis & Rheumatology, Journal of Hepatology, Journal of Biopharmaceutical Statistics and PLoS neglected tropical diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.